Archean Chemical Industries IPO Details: Price, Dates & Financials
The Archean Chemical Industries IPO is a closed mainboard Bookbuilding offer (Fresh Capital-cum-Offer for Sale) that opened on 9 November 2022. The Archean Chemical Industries IPO closed on 11 November 2022, with an issue price of ₹407 per share. The Archean Chemical Industries IPO has a face value of ₹2 and a lot size of 36 shares. The Archean Chemical Industries IPO is listed on 21 November 2022. The Archean Chemical Industries IPO allotment was scheduled for 16 November 2022.
On the financial front, the Archean Chemical Industries IPO reported revenue of ₹573 crore for 31-Mar-19, compared with ₹617 crore for 31-Mar-20. The Archean Chemical Industries IPO PAT was ₹40 crore against ₹-36 crore. The Archean Chemical Industries IPO net worth as of 31-Mar-19 was ₹42 crore.
Always verify The Archean Chemical Industries IPO details and GMP data with the official offer document before investing in the Archean Chemical Industries IPO.
Financial Summary
Amount in Crore
Metric
31-Mar-19
31-Mar-20
31-Mar-22
Total Assets
1,261
1,429
1,530
Revenue
573
617
1,143
PAT
40
-36
189
Net Worth
42
6
261
Total Borrowing
772
929
922
Archean Chemical Industries IPO Financials FAQs
Revenue of Archean Chemical Industries (Amount in Crore) — 31-Mar-19: 573; 31-Mar-20: 617; 31-Mar-22: 1,143. Profit after tax (PAT) — 31-Mar-19: 40; 31-Mar-20: -36; 31-Mar-22: 189.
Total assets — 31-Mar-19: 1,261; 31-Mar-20: 1,429; 31-Mar-22: 1,530. Net worth — 31-Mar-19: 42; 31-Mar-20: 6; 31-Mar-22: 261. (Amount in Crore)
Total borrowing of Archean Chemical Industries (Amount in Crore) — 31-Mar-19: 772; 31-Mar-20: 929; 31-Mar-22: 922.
The financials shown for Archean Chemical Industries IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
